Skip to main content
Dhanuka Agritech Ltd. logo

Dhanuka Agritech Ltd. — Investor Relations & Filings

Ticker · DHANUKA ISIN · INE435G01025 LEI · 335800E4DLZIC7MSG125 BSE.NS Manufacturing
Open in API
Filings indexed 1,595 across all filing types
Latest filing 2025-03-07 Regulatory Filings
Country IN India
Listing BSE.NS DHANUKA

About Dhanuka Agritech Ltd.

https://www.dhanuka.com/

Dhanuka Agritech Ltd. specializes in the manufacturing and marketing of a comprehensive range of crop protection solutions, including insecticides, herbicides, fungicides, and plant growth regulators. The company maintains strategic technical collaborations with several global chemical innovators to bring advanced formulations to the agricultural sector. Its product portfolio is supported by a robust research and development infrastructure and an extensive distribution network that facilitates the delivery of integrated pest management and soil health solutions. The organization focuses on enhancing agricultural productivity through the provision of high-quality inputs and technical advisory services. By leveraging a strong field force, it provides training and support to optimize crop yields and resource efficiency, ensuring the effective application of its diverse chemical and biological offerings.

Recent filings

Filing Released Lang Actions
Reply to Clarification- Financial results
Regulatory Filings
2025-03-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) informing them about the schedule of an Analyst/Institutional Investors Meet. It mentions the date, event name, organizer, and venue for the meeting. The content is about notifying the market and regulators of an upcoming investor presentation event, not the presentation itself or any financial data. The document is short (1729 characters) and serves as an announcement of a meeting rather than a detailed investor presentation or financial report. Therefore, it fits the category of Investor Presentation (IP) as it relates to investor communication events, but since it only announces the schedule and does not contain the presentation content, it is best classified as Regulatory Filings (RNS) as a general regulatory announcement about investor meetings under SEBI regulations.
2025-02-24 English
Intimation of schedule of Analyst / Institutional Investors Meet
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) informing them about the schedule of an Analyst/Institutional Investors Meet. It mentions the date, event name, organizer, and venue for the meeting. The content is about notifying the market and regulators of an upcoming investor presentation event, not the presentation itself or any financial data. The document is short (1729 characters) and serves as an announcement of a meeting rather than a report or transcript. Therefore, it fits the category of Investor Presentation (IP) related announcement, but since it is only an intimation of the schedule and not the presentation material itself, it is best classified as Regulatory Filings (RNS) as a general regulatory announcement under SEBI regulations.
2025-02-24 English
Intimation of Analysts/Investors meet
Regulatory Filings
2025-02-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-02-19 English
Transcript of Conference Call held on 3rd February, 2025 with Analysts/Investors to discuss Un-Audited Standalone & Consolidated Financial Results of the Company for the Quarter and Nine-Month ....
Call Transcript Classification · 100% confidence The document is a detailed transcript of a conference call held on February 3, 2025, discussing the company's un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. It includes management commentary, financial performance data, strategic updates, and a Q&A session with analysts and investors. The presence of a full transcript of the earnings call, including management remarks and Q&A, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive content typical of earnings call transcripts, not just a brief announcement or summary.
2025-02-06 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.